Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study.

Autor: Bayrasheva VK; Institute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, Russia., Pchelin IY; Department of Faculty Therapy, Saint Petersburg State University,, Saint Petersburg, Russia., Dobronravov VA; Research Institute of Nephrology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia., Babenko AY; Institute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, Russia., Chefu SG; Experimental Research Laboratory, Laser Medicine Center, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia., Shatalov IS; Scientific and Research Institute of Bioengineering, Saint Petersburg National Research University of Information, Technologies, Mechanics and Optics, Saint Petersburg, Russia., Vasilkova VN; Department of Internal Medicine No.1 with the Course of Endocrinology, Gomel State Medical University, Gomel, Belarus., Hudiakova NV; Department of Faculty Therapy, Saint Petersburg State University,, Saint Petersburg, Russia., Ivanova AN; Department of Faculty Therapy, Saint Petersburg State University,, Saint Petersburg, Russia., Andoskin PA; Laboratory of Protein Biochemistry, State Research Institute of Highly Pure BioSubstances, Saint Petersburg, Russia., Grineva EN; Institute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, Russia.

Publikováno v: Archives of endocrinology and metabolism [Arch Endocrinol Metab] 2020 Aug; Vol. 64 (4), pp. 418-426. Date of Electronic Publication: 2020 Apr 06.